Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Hospital, physician prices jumped over the last 5 years

Hospital prices continue to rise and are a major contributor to overall spending in the healthcare sector, which is expected to hit $6 trillion by 2027.

Thumbnail

Out-of-network billing rises, leaving patients with surprise expenses

Out-of-network billing in emergency departments has risen over the last few years, often leaving patients with surprise expenses even when they have insurance coverage and receive care from an in-network hospital.

Thumbnail

Eli Lilly’s half-price insulin hard to obtain

After drug manufacturer Eli Lilly introduced a half-priced insulin product to the U.S. market, patients are having trouble getting the medication, the Financial Times reported.

Thumbnail

AI emerging as healthcare leaders’ top toolset for reducing risk

Healthcare leaders working for provider organizations and medical societies see AI as the best emerging technology for reducing risk. Meanwhile they see online media as the riskiest technology.

Thumbnail

HHS directs $400M to battle opioid abuse epidemic

HHS has awarded $400 million through the Health Resources and Services Administration (HRSA) to fund community health centers, rural organizations and academic institutions to develop and expand services to combat the opioid abuse crisis.

Thumbnail

Editor’s pick: 8 data-driven healthcare trends to watch

AI, blockchain and mHealth apps specific to Big Data are among eight emerging technologies healthcare watchers would do well to keep an eye on, according to a consumer-friendly roundup published Aug. 7 in the Santa Clarita Valley Signal. 

Thumbnail

Pricey cancer treatment will be covered by Medicare

CMS has decided to cover an expensive and new therapy that uses a patient’s own genetically modified immune cells to treat cancer.

Thumbnail

Patients want price transparency in healthcare, but don’t really shop around

Pricing transparency is key for patients having a positive billing experience with their healthcare provider, according to a new survey, but patients aren’t always asking for price estimates or taking the time to shop around for lower-cost services.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup